1. Eighth International Symposium on hereditary breast and ovarian cancer

   Abstracts 15 September 2021 Pages: 255 - 288

   

2. A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel

   • Gili Reznick Levi
   • Gal Larom
   • Karin Weiss

   Original Article 17 May 2021 Pages: 289 - 294

   

3. Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer

   • Kyra Bokkers
   • Ronald P. Zweemer
   • Margreet G. E. M. Ausems

   Original Article Open access 07 October 2021 Pages: 295 - 304

   

4. Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant

   • Yael Laitman
   • Sarah M. Nielsen
   • Eitan Friedman

   Short Communication 08 October 2021 Pages: 305 - 308

5. Identification of women at risk of hereditary breast–ovarian cancer among participants in a population-based breast cancer screening

   • Luigina Bonelli
   • Ivana Valle
   • Liliana Varesco

   Original Article 20 October 2021 Pages: 309 - 318

   

6. A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman

   • Elise Pierre-Noël
   • Fabrice Airaud
   • Caroline Abadie

   Short Communication 14 September 2021 Pages: 319 - 324

   

7. Familial colorectal cancer and tooth agenesis caused by an AXIN2 variant: how do we detect families with rare cancer predisposition syndromes?

   • Janni M. Jensen
   • Anne Skakkebæk
   • Lone Sunde

   Original Article 12 October 2021 Pages: 325 - 332

   

8. Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome

   • Leatrisse Oba
   • Ana F. Best
   • Payal P. Khincha

   Short Communication 02 June 2021 Pages: 333 - 336

   

9. A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven

   • Rieko Taniguchi
   • Hideki Muramatsu
   • Yoshiyuki Takahashi

   Short Communication 22 June 2021 Pages: 337 - 341

   

10. PTCH2 is not a strong candidate gene for gorlin syndrome predisposition

    • Miriam J. Smith
    • D. Gareth Evans

    Short Communication Open access 25 June 2021 Pages: 343 - 346

11. Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family

    • Kevin M. Brown
    • Mai Xu
    • Maria Teresa Landi

    Original Article 03 July 2021 Pages: 347 - 355

    

12. Uterine leiomyomatosis in adolescents and young adults (AYAs) may represent a narrow phenotypic variant of FH tumour predisposition syndrome

    • Tiffany Foo
    • Vivek Nama
    • Terri P. McVeigh

    Short Communication 14 September 2021 Pages: 357 - 362

    

13. Fibroadenoma in vulval ectopic breast tissue in a patient with PTEN Hamartoma Tumour Syndrome

    • Hannah Dawson
    • Alannah Smrke
    • Terri P. McVeigh

    Short Communication 15 September 2021 Pages: 363 - 368

    

14. Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program

    • Eryn F. Braley
    • Angela C. Bedard
    • Kasmintan A. Schrader

    Short Communication 07 July 2021 Pages: 369 - 374

    

15. Outcomes of retesting in patients with previously uninformative cancer genetics evaluations

    • Shenin A. Dettwyler
    • Erika S. Koeppe
    • Elena M. Stoffel

    Original Article 21 September 2021 Pages: 375 - 385

    

16. Correction to: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations

    • Shenin A. Dettwyler
    • Erika S. Koeppe
    • Elena M. Stoffel

    Correction 28 October 2021 Pages: 387 - 388